What has been overlooked on study of Chinese materia medica in the West? - Wikidata - awgldk - TriplyDB

What has been overlooked on study of Chinese materia medica in the West?

What has been overlooked on study of Chinese materia medica in the West?

http://www.wikidata.org/entity/Q38544110

about

Effect of Guizhifulingwan (Keishibukuryogan) on climacteric syndrome: study protocol for a randomized controlled pilot trial.Jiangtang Xiaozhi Recipe () prevents diabetic retinopathy in streptozotocin-induced diabetic rats.

P2860

Q37715758-D6B1DDB0-4D2E-49AE-BBA9-233A3F897E71 Q51282796-7AE29DA4-FE9C-470B-A4A6-D1B2CDEA4812

P2860

What has been overlooked on study of Chinese materia medica in the West?

http://www.wikidata.org/entity/Q38544110

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

What has been overlooked on study of Chinese materia medica in the West?

@en

type

label

What has been overlooked on study of Chinese materia medica in the West?

@en

prefLabel

What has been overlooked on study of Chinese materia medica in the West?

@en

P1433

Q38544110-DD69489D-35F3-499F-AD35-E169078841B1

P1476

Q38544110-59F6756A-4A91-43EC-A362-1E2CD5995D0E

P2093

Q38544110-019D79D6-D57F-4657-8B3C-2112ED7E229A

P2860

Q38544110-0CC4546C-B321-4D95-94C3-6F5150529B25

Q38544110-15368F1A-F6EC-462D-A030-1D2C31838261

Q38544110-170284B6-4075-45B3-B141-0D51A518B37B

Q38544110-1DED701E-3E4B-440A-90AF-6364E82D70C1

Q38544110-26B000E6-D89B-420F-BC34-C38C3B27A686

Q38544110-2CD2E326-1E37-4A3C-A13B-DC79B02EC74C

Q38544110-36C7B32D-A6AE-44DC-9D95-03E54D6FFD11

Q38544110-41734882-5237-4EF3-961A-96994346F7A7

Q38544110-4D372411-B948-459C-8127-7AD3583A8042

Q38544110-72AB093B-9660-4B3A-849D-55C8C128138B

P2888

Q38544110-E38EBC20-B1B3-4729-92F2-645BE42882DF

P304

Q38544110-03DAF346-53E2-4E0D-BACC-3CE0058AA76E

P31

Q38544110-05F1E082-7014-4027-8B1F-5F0BA1713135

P356

Q38544110-313CD0BA-F5AB-4B5D-B31E-60213A5C3864

P433

Q38544110-4C421134-5547-48A5-A580-577076E86FC4

P478

Q38544110-D997C6B5-C5A5-4187-ABAC-5A5BCE1B34FF

P577

Q38544110-3D1666D4-D7C9-4263-8B5C-275CCE0CBA68

P6179

Q38544110-7275A7B7-0988-40EC-A8A3-305C5E9A0A42

P698

Q38544110-0223549B-1C02-4C91-93E2-A0584B2C6738

P921

Q38544110-72D68B96-9AE7-405A-8A5D-2C273A657C0D

P356

S11655-015-2081-X

P1433

Chinese Journal of Integrated Medicine

P1476

What has been overlooked on study of Chinese materia medica in the West?

@en

P2093

Willow J H Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Introduction: the history of arsenic trioxide in cancer therapy.

The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine.

Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy.

Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial.

Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis.

Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design

The revolutionary health science of psychoendoneuroimmunology: a new paradigm for understanding health and treating illness.

Syndrome differentiation in modern research of traditional Chinese medicine.

The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease.

Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms.

P2888

s11655-015-2081-x

P304

483-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11655-015-2081-X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003550657

http://www.w3.org/2001/XMLSchema#string

P698

26156100

http://www.w3.org/2001/XMLSchema#string

P921